Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2012) Sagnik Bhattacharyya   ARCHIVES OF GENERAL PSYCHIATRY

Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?

(2012) Daniël Kleinloog et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabinoids attenuate hippocampal gamma oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells

(2011) Noémi Holderith et al.   JOURNAL OF PHYSIOLOGY-LONDON

Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence

(2011) J M Stone et al.   MOLECULAR PSYCHIATRY

Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study

(2011) Toby T Winton-Brown et al.   NEUROPSYCHOPHARMACOLOGY

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

(2011) Christian D. Schubart et al.   SCHIZOPHRENIA RESEARCH

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

(2010) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Central nervous system effects of haloperidol on THC in healthy male volunteers

(2010) M Liem-Moolenaar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study

(2010) Emma Barkus et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Review: Inequalities in healthcare provision for people with severe mental illness

(2010) David Lawrence et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms

(2010) Paul D Morrison et al.   NEUROPSYCHOPHARMACOLOGY

Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines

(2010) Rebecca Kuepper et al.   SCHIZOPHRENIA RESEARCH

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Cannabis and psychosis/schizophrenia: human studies

(2009) Deepak Cyril D’Souza et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Reduced expression of glutamate receptors and phosphorylation of CREB are responsible forin vivoΔ9-THC exposure-impaired hippocampal synaptic plasticity

(2009) Ni Fan et al.   JOURNAL OF NEUROCHEMISTRY

Alteration of Theta Timescale Dynamics of Hippocampal Place Cells by a Cannabinoid Is Associated with Memory Impairment

(2009) D. Robbe et al.   JOURNAL OF NEUROSCIENCE

Can recreational doses of THC produce significant dopamine release in the human striatum?

(2009) Paul R.A. Stokes et al.   NEUROIMAGE

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

(2009) P. D. Morrison et al.   PSYCHOLOGICAL MEDICINE

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

(2008) Matthijs G Bossong et al.   NEUROPSYCHOPHARMACOLOGY

Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample

(2008) E. Barkus et al.   PSYCHOLOGICAL MEDICINE

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans

(2008) Deepak Cyril D’Souza et al.   PSYCHOPHARMACOLOGY

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY